Company Filing History:
Years Active: 1998
Title: **Yun-Yao Li: Innovating HIV-1 Inhibition Techniques**
Introduction
Yun-Yao Li, based in Flushing, NY, is a notable inventor with a focus on groundbreaking techniques in the field of medical research. With a significant patent to his name, he has contributed to the fight against HIV-1 through innovative methods for screening compounds that inhibit the virus's capacity to bind to receptors.
Latest Patents
Li's most recent patent, titled "Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to HIV-1 second receptors," highlights a sophisticated approach to combating HIV-1. The patented method involves preparing a magnetic ligand by mixing a magnetic, CD4-containing substrate with HIV-1, subsequently testing various compounds for their effectiveness in inhibiting the binding process. The steps include mixing the magnetic ligand with a test compound, adding cells expressing HIV-1 second receptors, and employing a magnetic separator to isolate and quantify the cells with bound ligands.
Career Highlights
Currently, Yun-Yao Li is associated with the New York Blood Center, Inc., where he applies his expertise to enhance research methodologies and therapeutic strategies related to blood and pathogens. His innovative work at this institution underlines his commitment to advancing public health through scientific research.
Collaborations
Throughout his career, Li has collaborated with esteemed colleagues including Alexander Robert Neurath and Asim Kumar Debnath. Together, they strive to push the boundaries of knowledge in virology and therapeutic interventions, contributing to the collaborative spirit that is essential in scientific progress.
Conclusion
Yun-Yao Li exemplifies the spirit of innovation within the realm of medical research. His contributions, particularly through his patent focusing on HIV-1, are vital to understanding and combating viral infections. As a dedicated inventor, he continues to inspire researchers and healthcare professionals alike in the ongoing battle against HIV and similar diseases.
